June 29, 2020
Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced that Dr. Anand Patel, Chief of Interventional Radiology, Providence Little Company of Mary Medical Centers in Torrance, and San Pedro with Advanced Imaging of South Bay, has joined the company’s advisory board.
“We are pleased to have a visionary vascular specialist and AI innovator like Dr. Patel join our Medical Advisory Board,” said David Cuccia, President, CTO and Founder. “About one-third of people with diabetes develop foot ulcers which can frequently lead to amputation and death. We look forward to working with Dr. Patel to gain his unique insights on how our Clarifi solution can be best positioned to address the ill-met clinical requirements of endovascular specialists, podiatrists, and advanced wound care providers who diagnose and treat these vulnerable patients.”
“I’m excited to be advising this very talented Modulim team to advance the technology and educate clinicians, healthcare providers and Payers on the how Clarifi can help prevent diabetic foot ulcers and amputations,” said Dr. Anand Patel. “I believe the Company is poised to bring needed innovation to the vascular specialty with their solution roadmap that would combine a novel, non-contact optical imaging capability with predictive artificial intelligence decision support.”
Dr. Patel has a degree in Bioengineering from the University of Pennsylvania, and an MD from Harvard Medical School. He completed his Radiology residency and Vascular & Interventional Fellowship at the University of California at San Francisco. Dr. Patel has an innovative clinical, research, and entrepreneurial background with patent-pending medical devices. He was Founder/CEO of med device startup in the interventional oncology space that was successfully acquired. Dr. Patel’s interests lie in interventional radiology, peripheral arterial disease, med devices, artificial intelligence, and developing novel advanced imaging technologies including. His peers have selected him as a top doctor featured in 2018 by LA Magazine. Dr. Patel’s work has been published in multiple peer-reviewed publications and presented at numerous international conferences. He has worked extensively with the med device industry on advanced R&D, FDA clearance, and reimbursement from CMS.
Modulim delivers transformative optical solutions that help people live healthier, longer lives. Clarifi, powered by Spatial Frequency Domain Imaging (SFDI) technology, identifies compromised circulation at the point of care through non-contact rapid microvascular assessment of tissue. Clinicians and healthcare systems are empowered by SFDI images to make proactive, data-driven decisions in a multidisciplinary care setting, in order to reduce lower-limb complications caused by diabetes and peripheral arterial disease. Founded by the inventors of SFDI at the University of California Irvine, Modulim is based in Irvine, CA with a team dedicated to delivering powerful healthcare solutions that elevate and standardize health care delivery, while improving patient outcomes. Modulim is backed by Pangaea Ventures, Fresenius Medical Care Ventures, Grey Sky Venture Partners, Mitsubishi Capital, Hamamatsu Photonics, The Cove Fund at UCI Applied Innovation, and Fouse KK.
Clarifi is a registered trademark of Modulated Imaging (dba Modulim).